These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37730103)

  • 1. Personalized neoantigen cancer vaccines: An analysis of the clinical and commercial potential of ongoing development programs.
    Perrinjaquet M; Richard Schlegel C
    Drug Discov Today; 2023 Nov; 28(11):103773. PubMed ID: 37730103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the development of personalized neoantigen-based therapeutic cancer vaccines.
    Blass E; Ott PA
    Nat Rev Clin Oncol; 2021 Apr; 18(4):215-229. PubMed ID: 33473220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What's next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination.
    Redwood AJ; Dick IM; Creaney J; Robinson BWS
    Oncoimmunology; 2022; 11(1):2038403. PubMed ID: 35186441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoantigen cancer vaccines: a new star on the horizon.
    Li X; You J; Hong L; Liu W; Guo P; Hao X
    Cancer Biol Med; 2023 Dec; 21(4):274-311. PubMed ID: 38164734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
    Aldous AR; Dong JZ
    Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in personalized neoantigen vaccines for cancer immunotherapy.
    Sun C; Xu S
    Biosci Trends; 2020 Nov; 14(5):349-353. PubMed ID: 32908077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy.
    Richard G; Princiotta MF; Bridon D; Martin WD; Steinberg GD; De Groot AS
    Expert Rev Vaccines; 2022 Feb; 21(2):173-184. PubMed ID: 34882038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Driving neoantigen-based cancer vaccines for personalized immunotherapy into clinic: A burdensome journey to promising land.
    Yu G; He X; Li X; Wu Y
    Biomed Pharmacother; 2022 Sep; 153():113464. PubMed ID: 36076493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering neoantigen vaccines to improve cancer personalized immunotherapy.
    Liu Z; Lv J; Dang Q; Liu L; Weng S; Wang L; Zhou Z; Kong Y; Li H; Han Y; Han X
    Int J Biol Sci; 2022; 18(15):5607-5623. PubMed ID: 36263174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized neoantigen vaccines: a glimmer of hope for glioblastoma.
    Londhe VY; Date V
    Expert Rev Vaccines; 2020 May; 19(5):407-417. PubMed ID: 32238056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough concepts in immune-oncology: Cancer vaccines at the bedside.
    Roy S; Sethi TK; Taylor D; Kim YJ; Johnson DB
    J Leukoc Biol; 2020 Oct; 108(4):1455-1489. PubMed ID: 32557857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy.
    Supabphol S; Li L; Goedegebuure SP; Gillanders WE
    Expert Opin Investig Drugs; 2021 May; 30(5):529-541. PubMed ID: 33641576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer neoantigen: Boosting immunotherapy.
    Xu P; Luo H; Kong Y; Lai WF; Cui L; Zhu X
    Biomed Pharmacother; 2020 Nov; 131():110640. PubMed ID: 32836075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic cancer vaccines: From initial findings to prospects.
    Song Q; Zhang CD; Wu XH
    Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized cancer neoantigen vaccines come of age.
    Chu Y; Liu Q; Wei J; Liu B
    Theranostics; 2018; 8(15):4238-4246. PubMed ID: 30128050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development.
    Lancaster EM; Jablons D; Kratz JR
    Genet Test Mol Biomarkers; 2020 Feb; 24(2):59-66. PubMed ID: 30907630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomaterials-assisted construction of neoantigen vaccines for personalized cancer immunotherapy.
    Wu Y; Feng L
    Expert Opin Drug Deliv; 2023 Mar; 20(3):323-333. PubMed ID: 36634017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The perfect personalized cancer therapy: cancer vaccines against neoantigens.
    Aurisicchio L; Pallocca M; Ciliberto G; Palombo F
    J Exp Clin Cancer Res; 2018 Apr; 37(1):86. PubMed ID: 29678194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PERSONALIZED NEOANTIGEN VACCINE AGAINST CANCER.
    Pavelić K
    Psychiatr Danub; 2021 May; 33(Suppl 3):S331-S335. PubMed ID: 34010258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer Vaccine Focused on Neoantigens].
    Shindo Y; Hazama S; Nagano H
    Gan To Kagaku Ryoho; 2019 Sep; 46(9):1367-1371. PubMed ID: 31530772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.